Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DBFAF925.svg?ark=w1%2F20260515%2FDBFAF925)](https://nobleid.org/work/w1/20260515/DBFAF925)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors